Medical device company Cibiem has appointed Ken Martin to president and chief executive officer. Martin will succeed Cibiem co-founder Howard R. Levin who will continue his active involvement within the company and as a member of its board of directors.The company is backed by SV Life Sciences and Third Rock Ventures.

SV Life Sciences said Monday that Darren Black was named a managing partner while Tom Flynn was made a partner. Black joined SV Life Sciences in 2003 and will continue to focus on healthcare services, pharmaceutical services and healthcare information technology. Flynn joined the life sciences VC firm in 2011 and targets post-acute care delivery and healthcare information technology services.

Health Essentials, a provider of post-acute care management services, has raised an undisclosed amount of funding from SV Life Sciences and Bessemer Venture Partners. Health Essentials, which provides care to the frail and elderly population in California, Nevada and Arizona, aims to use the growth funding to expand into new geographies. As part of the funding, Stephen Kraus from Bessemer and Tom Flynn from SV Life Sciences, have joined the board.

San Francisco-based Sutro Biopharma has closed a $16.5 million second tranche of its Series C financing. The financing was led by Skyline Ventures and included participation of Lilly Ventures, Amgen Ventures, SV Life Sciences and Alta Partners. Sutro has raised almost $60 million since its founding in 2003. PRESS RELEASE Sutro Biopharma today announced the [...]

Medical device company CardioKinetix has apointed Maria Sainz as president and chief executive officer. Recently Sainz served as general manager of Stryker Neurovascular, which acquired Concentric Medical in October 2011 under her leadership as president and CEO. CardioKinetix is backed by SV Life Sciences, New Leaf Venture Partners, U.S. Venture Partners, Panorama Capital, and H&Q [...]

WellNow Urgent Care has lauched with $35 million in committed capital from investors including SV Life Sciences, Petra Capital Partners and River Cities Capital Funds. Nashville, Tenn-based WellNow focuses on treating patients in underserved markets. PRESS RELEASE WellNow Urgent Care, a new urgent care company focused on treating patients in underserved markets, has launched operations [...]

TransEnterix Inc. has closed a $15 million in venture capital financing. TransEnterix currently markets throughout Europe and the US a platform called the SPIDER® Surgical System. The funding is the second tranche of the company’s Series B financing secured in 2009. Aisling Capital, Quaker BioVentures, Intersouth Partners, Synergy Life Science Partners and SV Life Sciences [...]

Massachusetts-based Catabasis Pharmaceuticals raised an additional $8 million in its Series A financing, now bringing its total funding for the round to $47.6 million. The company is developing an omega-3 conjugated compound for patients with severe hypertriglyceridemia. SV Life Sciences, Clarus Ventures, MedImmune Ventures and Advanced Technology Ventures all participated in the funding.

Imperial Innovations Group, a technology commercialisation and investment group, and SV Life Sciences have committed to invest 8 million pounds ($12.52 million) in new start-up company TopiVert. The start-up will focus on developing topical medicines for inflammatory diseases of the eye and gut. PRESS RELEASE Imperial Innovations Group plc (AIM: IVO, ‘Innovations’), a leading technology [...]

AcuFocus a maker of corneal inlay, has closed a $65 million financing round led by Cowen Healthcare Royalty Partners. Existing investors SV Life Sciences, Versant Ventures, Carlyle Group, Accuitive Medical Ventures and Bausch & Lomb participated, with Medtronic also joining in the round. Cowen Royalty’s $30 million investment included a $25 million Synthetic Royalty(SM) investment [...]